INSM - Insmed Inc
IEX Last Trade
76.45
0.120 0.157%
Share volume: 1,721,936
Last Updated: Fri 30 Aug 2024 09:59:57 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$76.33
0.12
0.16%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-04 | 2022-10-27 | 2023-02-23 | 2023-05-04 | 2023-08-03 | 2023-10-26 | 2024-02-22 | 2024-05-09 | |
| Total revenue | 65.221 M | 67.730 M | 59.300 M | 65.214 M | 77.229 M | 79.072 M | 83.693 M | 75.500 M | |
| Cost of revenue | 16.395 M | 13.471 M | 13.069 M | 13.830 M | 16.594 M | 16.706 M | 18.443 M | 17.457 M | |
| Gross profit | 48.826 M | 54.259 M | 46.231 M | 51.384 M | 60.635 M | 62.366 M | 65.250 M | 58.043 M | |
| 11.13% | -14.80% | 11.15% | 18.00% | 2.85% | 4.62% | -11.05% | |||
| Operating expenses | 148.501 M | 175.455 M | 198.242 M | 207.779 M | 281.400 M | 199.774 M | 226.559 M | 214.185 M | |
| Selling general and admin | 59.974 M | 75.583 M | 73.479 M | 79.914 M | 84.431 M | 90.626 M | 89.530 M | 93.102 M | |
| Research and development | 88.527 M | 99.872 M | 124.763 M | 127.865 M | 196.969 M | 109.148 M | 137.029 M | 121.083 M | |
| Total expenses | 166.159 M | 190.189 M | 212.575 M | 222.872 M | 299.257 M | 217.743 M | 246.265 M | 232.905 M | |
| 14.46% | 11.77% | 4.84% | 34.27% | -27.24% | 13.10% | -5.43% | |||
| Operating income | -100.938 M | -122.459 M | -153.275 M | -157.658 M | -222.028 M | -138.671 M | -162.572 M | -157.405 M | |
| Ebit | -100.938 M | -122.459 M | -153.275 M | -157.658 M | -222.028 M | -138.671 M | -162.572 M | -157.405 M | |
| Pretax income | -95.144 M | -130.773 M | -159.998 M | -159.281 M | -244.279 M | -158.389 M | -185.063 M | -156.502 M | |
| 37.45% | 22.35% | -0.45% | 53.36% | -35.16% | 16.84% | -15.43% | |||
| Income tax | 501.000 K | 372.000 K | 125.000 K | 483.000 K | 530.000 K | 544.000 K | 998.000 K | 589.000 K | |
| Net income basic | -95.645 M | -131.145 M | -160.123 M | -159.764 M | -244.809 M | -158.933 M | -186.061 M | -157.091 M | |
| -37.12% | -22.10% | 0.22% | -53.23% | 35.08% | -17.07% | 15.57% | |||
| Net income | -95.645 M | -131.145 M | -160.123 M | -159.764 M | -244.809 M | -158.933 M | -186.061 M | -157.091 M | |
| -37.12% | -22.10% | 0.22% | -53.23% | 35.08% | -17.07% | 15.57% |